*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
"From Innovation to Impact: Developing Clinical Diagnostics for Low-Resource Settings"
Jay Gerlach, Technology Solutions Strategic Program
Jay Gerlach is a Commercialization Associate for PATH's Technology Solutions Strategic Program. His work in biotech has focused on gene therapy for cancer, as well as identifying the mechanism of action and eliminating the side effects of validated pharmaceuticals. His work in global health started in Seattle Biomedical Research Institute where he worked on the malaria antigen discovery (MAD) project headed by Patrick Duffy.
PATH is an international nonprofit that creates sustainable, culturally relevant solutions by advancing health technologies and encouraging healthy behaviors.
Support provided by the School of Public Policy and others
contact: melissa_li@gatech.edu, jeremy.lim@gatech.edu
Food and Refreshments provided
